Announced Mon, 6 Jul · 15:17 IST
Routine dematerialisation compliance certificate for Q1 FY27
Compliance View source PDF
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+0.0%1-day move
₹29.00
prior close
—
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
————+0.0+4.8+5.2+3.2-1.9-1.6+1.7———
Up moveDown movePending
AI summary
Genomic Valley Biotech filed a routine compliance certificate under SEBI Regulation 74(5) for the quarter ended 30 June 2026. Registrar Beetal Financial confirmed that all securities received for dematerialisation were processed and old share certificates were cancelled and replaced with depository holdings within 15 days. This is standard regulatory housekeeping with no financial impact.
Likely market impact
Routine compliance filing. No material impact on shareholders or stock price.